Cargando…

Biological drugs for inducing remission in patients with Crohn's disease: determining statistical equivalence according to evidence-based methods

Detalles Bibliográficos
Autores principales:	Messori, Andrea, Fadda, Valeria, Maratea, Dario, Trippoli, Sabrina, Marinai, Claudio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Termedia Publishing House 2015
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4424265/ https://www.ncbi.nlm.nih.gov/pubmed/25995767 http://dx.doi.org/10.5114/aoms.2015.50980

Ejemplares similares

Testing the Therapeutic Equivalence of Alogliptin, Linagliptin, Saxagliptin, Sitagliptin or Vildagliptin as Monotherapy or in Combination with Metformin in Patients with Type 2 Diabetes
por: Messori, Andrea, et al.
Publicado: (2014)

Subcutaneous Biological Treatments for Moderate to Severe Psoriasis: Interpreting Safety Data by Network Meta-Analysis
por: Messori, Andrea, et al.
Publicado: (2015)

New Oral Anticoagulants in Acute Coronary Syndrome: Is There Any Advantage Over Existing Treatments?
por: Messori, Andrea, et al.
Publicado: (2014)

Handling the procurement of prostheses for total hip replacement: description of an original value based approach and application to a real-life dataset reported in the UK
por: Messori, Andrea, et al.
Publicado: (2017)

Relationship Between Price and Diagnosis-Related Group Tariff for Medical Devices Assessed by a Regional Health Technology Assessment Committee
por: Trippoli, Sabrina, et al.
Publicado: (2022)

A Comparison of Statistical Analysis Between "Real" Patients Reported in Kaplan-Meier Curves and "Reconstructed" Patients Estimated Through the IPDfromKM Method: Analysis of Eight Trials Evaluating Catheter Ablation of Ventricular Tachycardia
por: Messori, Andrea, et al.
Publicado: (2023)

Managing Tenders in the Procurement of Advanced Medical Devices: An Original Model Based on the Net Monetary Benefit Combined With Three Clinical Endpoints
por: Messori, Andrea, et al.
Publicado: (2023)

Simplified figure to present direct and indirect comparisons: Revisiting the graph 10 years later
por: Fadda, Valeria, et al.
Publicado: (2021)

Infections in Patients Receiving Subcutaneous Biological Treatments for Moderate to Severe Psoriasis
por: Messori, Andrea, et al.
Publicado: (2015)

Long-term outcomes in chronic obstructive pulmonary disease patients: exploring the effects of inhalatory devices and their influence on the outcome
por: Fadda, Valeria, et al.
Publicado: (2016)

Value-based procurement of prostheses for total knee replacement
por: Messori, Andrea, et al.
Publicado: (2018)

Estimation of Value-Based Price for Five High-Technology Medical Devices Approved by a Regional Health Technology Assessment Committee in Italy
por: Messori, Andrea, et al.
Publicado: (2022)

Early and intermediate survival after transcatheter aortic valve implantation: systematic review and meta-analysis of 14 studies
por: Messori, Andrea, et al.
Publicado: (2013)

Differences in Effectiveness among Devices for Endovascular Thrombectomy in Patients with Acute Ischemic Stroke
por: Chiumente, Marco, et al.
Publicado: (2016)

The restricted mean survival time as a replacement for the hazard ratio and the number needed to treat in long‐term studies
por: Messori, Andrea, et al.
Publicado: (2021)

Antithrombin III in patients admitted to intensive care units: a multicenter observational study
por: Messori, Andrea, et al.
Publicado: (2002)

The limitations of observational studies on the treatment of severe sepsis – authors' response
por: Messori, Andrea, et al.
Publicado: (2002)

Estimation of Value-Based Price for 48 High-Technology Medical Devices
por: Hyeraci, Giulia, et al.
Publicado: (2023)

Medical Therapy, Radiofrequency Ablation, or Cryoballoon Ablation as First-Line Treatment for Paroxysmal Atrial Fibrillation: Interpreting Efficacy Through the Shiny Method
por: Trippoli, Sabrina, et al.
Publicado: (2022)

Will the Inducing and Maintaining Remission of Non-biological Agents and Biological Agents Differ for Crohn's Disease? The Evidence From the Network Meta-Analysis
por: Rui, Mingjun, et al.
Publicado: (2021)

Statistical method for the determination of equivalence of automated test procedures
por: Lung, K. Rick, et al.
Publicado: (2003)

Crohn’s disease in remission or simply smouldering?
por: Gaya, Daniel R.
Publicado: (2015)

Determination of lower cut‐off levels of adalimumab associated with biochemical remission in Crohn's disease
por: Carlsen, Arne, et al.
Publicado: (2019)

Vedolizumab for induction and maintenance of remission in Crohn's disease
por: Hui, Samuel, et al.
Publicado: (2023)

Infliximab for medical induction of remission in Crohn's disease
por: Gordon, Morris, et al.
Publicado: (2023)

5-Aminosalicylates to maintain remission in Crohn’s disease: Interpreting conflicting systematic review evidence
por: Gordon, Morris
Publicado: (2017)

Clinical perspective on statistical equivalence
por: Goudra, Basavana G, et al.
Publicado: (2013)

Effectiveness of Crohn’s Disease Exclusion Diet for Induction of Remission in Crohn’s Disease Adult Patients
por: Szczubełek, Martyna, et al.
Publicado: (2021)

Survival in patients with intermediate or high grade non-Hodgkin's lymphoma: meta-analysis of randomized studies comparing third generation regimens with CHOP
por: Messori, A, et al.
Publicado: (2001)

Lactobacillus GG in inducing and maintaining remission of Crohn's disease
por: Schultz, Michael, et al.
Publicado: (2004)

Remission in Crohn’s disease is accompanied by alterations in the gut microbiota and mucins production
por: Magro, Daniéla Oliveira, et al.
Publicado: (2019)

Biologic monotherapy versus combination therapy with immunomodulators in the induction and maintenance of remission of Crohn’s disease and ulcerative colitis
por: Hashash, Jana G., et al.
Publicado: (2021)

Testing Statistical Hypotheses of Equivalence and Noninferiority
por: Wellek, Stefan
Publicado: (2010)

Crohn’s Disease in Clinical Remission Is Marked by Systemic Oxidative Stress
por: Bourgonje, Arno R., et al.
Publicado: (2019)

Combined evaluation of biomarkers as predictor of maintained remission in Crohn’s disease
por: Sollelis, Elisa, et al.
Publicado: (2019)

Post-Induction High Adalimumab Drug Levels Predict Biological Remission at Week 24 in Patients With Crohn's Disease
por: Zittan, Eran, et al.
Publicado: (2021)

Endoscopic activity, tissue factor and Crohn’s disease: findings in clinical remission patients
por: Andrade, Adriana Ribas, et al.
Publicado: (2020)

Time to achieve remission determines time to be in remission
por: Schipper, Lydia G, et al.
Publicado: (2010)

Structural Imaging Changes and Behavioral Correlates in Patients with Crohn’s Disease in Remission
por: Nair, Veena A., et al.
Publicado: (2016)

Alterations in resting-state functional connectivity in patients with Crohn’s disease in remission
por: Hou, Jiancheng, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_i0go3766r2iudjl1j0u23adpi4